Cargando…

Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo

We aimed to identify potent biliverdin reductase (BVRA) inhibitors as a novel concept for the treatment of severe unconjugated hyperbilirubinemia. 1280 FDA-approved compounds were screened in vitro for their ability to inhibit human and rat BVRA activity and 26 compounds were identified as BVRA in...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Dijk, Remco, Aronson, Sem J., de Waart, Dirk R., van de Graaf, Stan F., Duijst, Suzanne, Seppen, Jurgen, Elferink, Ronald Oude, Beuers, Ulrich, Bosma, Piter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431759/ https://www.ncbi.nlm.nih.gov/pubmed/28490767 http://dx.doi.org/10.1038/s41598-017-01602-w

Ejemplares similares

A novel UGT1A1 gene mutation causing severe unconjugated hyperbilirubinemia: a case report
por: Shi, Xiaoxia, et al.
Publicado: (2019)

Long-Term Effects of Biliverdin Reductase a Deficiency in Ugt1(−/−) Mice: Impact on Redox Status and Metabolism
por: Bortolussi, Giulia, et al.
Publicado: (2021)

Reduced spontaneous itch in mouse models of cholestasis
por: Langedijk, Jacqueline, et al.
Publicado: (2021)

Efficacy of AAV8-hUGT1A1 with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients
por: Shi, Xiaoxia, et al.
Publicado: (2020)

A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene
por: Aronson, Sem J., et al.
Publicado: (2020)

Evaluation of Treatment Thresholds for Unconjugated Hyperbilirubinemia in Preterm Infants: Effects on Serum Bilirubin and on Hearing Loss?
por: Hulzebos, Christian V., et al.
Publicado: (2013)

Low efficacy of recombinant SV40 in Ugt1a1(-/-) mice with severe inherited hyperbilirubinemia
por: Shi, Xiaoxia, et al.
Publicado: (2021)

Direct Antioxidant Properties of Bilirubin and Biliverdin. Is there a Role for Biliverdin Reductase?
por: Jansen, Thomas, et al.
Publicado: (2012)

A possible case of bictegravir-associated severe unconjugated hyperbilirubinemia
por: Parmar, Kanak, et al.
Publicado: (2023)

Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice
por: Kunst, Roni F., et al.
Publicado: (2022)

Optimizing Exchange Transfusion for Severe Unconjugated Hyperbilirubinemia: Studies in the Gunn Rat
por: Schreuder, Andrea B., et al.
Publicado: (2013)

Gilbert Syndrome with Concomitant Hereditary Spherocytosis Presenting with Moderate Unconjugated Hyperbilirubinemia
por: Aiso, Mitsuhiko, et al.
Publicado: (2017)

Atazanavir-induced unconjugated hyperbilirubinemia prevents vascular hyporeactivity during experimental human endotoxemia
por: Dorresteijn, Mirrin J., et al.
Publicado: (2023)

Biliverdin reductase: a target for cancer therapy?
por: Gibbs, Peter E. M., et al.
Publicado: (2015)

Genetic Spectrum of UGT1A1 in Korean Patients with Unconjugated Hyperbilirubinemia
por: Kim, Jin Ju, et al.
Publicado: (2020)

Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+)-taurocholate cotransporting polypeptide knockout mice
por: Slijepcevic, Davor, et al.
Publicado: (2015)

Go Green: The Anti-Inflammatory Effects of Biliverdin Reductase
por: Wegiel, Barbara, et al.
Publicado: (2012)

Unconjugated hyperbilirubinemia in a blood donor: Chance finding due to unusual plasma discoloration
por: Jain, Ashish, et al.
Publicado: (2018)

Characteristics of the heme catabolic pathway in mild unconjugated hyperbilirubinemia and their associations with inflammation and disease prevention
por: Mölzer, Christine, et al.
Publicado: (2017)

Biliverdin Reductase: More than a Namesake – The Reductase, Its Peptide Fragments, and Biliverdin Regulate Activity of the Three Classes of Protein Kinase C
por: Gibbs, Peter E. M., et al.
Publicado: (2012)

Gene Therapy for Progressive Familial Intrahepatic Cholestasis: Current Progress and Future Prospects
por: Bosma, Piter J., et al.
Publicado: (2020)

Gilbert syndrome with systemic lupus erythematosus presenting with persistent unconjugated hyperbilirubinemia: A case report
por: Ye, Naifang, et al.
Publicado: (2020)

Hyperbilirubinemia Maintained by Chronic Supplementation of Unconjugated Bilirubin Improves the Clinical Course of Experimental Autoimmune Arthritis
por: Sykora, Tomas, et al.
Publicado: (2021)

“Gilbert’s-like” syndrome as part of a spectrum of persistent unconjugated hyperbilirubinemia in post-chronic hepatitis patients
por: Ye, Jin, et al.
Publicado: (2018)

The Spectrum of Hemolytic Disease of the Newborn: Evaluating the Etiology of Unconjugated Hyperbilirubinemia Among Neonates Pertinent to Immunohematological Workup
por: Routray, Suman S, et al.
Publicado: (2021)

Role of transcranial Doppler in assessment of cerebral blood flow in full term neonates with extreme unconjugated hyperbilirubinemia
por: Kamel, Sara Mahmoud, et al.
Publicado: (2022)

Adeno-Associated Viral Vector Serotype 5 Poorly Transduces Liver in Rat Models
por: Montenegro-Miranda, Paula S., et al.
Publicado: (2013)

Identification of Promotor and Exonic Variations, and Functional Characterization of a Splice Site Mutation in Indian Patients with Unconjugated Hyperbilirubinemia
por: Gupta, Neha, et al.
Publicado: (2015)

Autotaxin, PPARs, and FGF21: An Eye Opener for Progressive Liver Disease?
por: Beuers, Ulrich, et al.
Publicado: (2022)

Intestinal Farnesoid X Receptor Activation by Pharmacologic Inhibition of the Organic Solute Transporter α-β
por: van de Wiel, Sandra M.W., et al.
Publicado: (2017)

Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells
por: Sokolović, Aleksandar, et al.
Publicado: (2010)

Modulating Enzyme Function via Dynamic Allostery within Biliverdin Reductase B
por: Redzic, Jasmina S., et al.
Publicado: (2021)

Identifying structural and dynamic changes during the Biliverdin Reductase B catalytic cycle
por: Lee, Eunjeong, et al.
Publicado: (2023)

Biliverdin Reductase A (BVRA) Mediates Macrophage Expression of Interleukin-10 in Injured Kidney
por: Hu, Zhizhi, et al.
Publicado: (2015)

Subarachnoid Hemorrhage Increases Level of Heme Oxygenase-1 and Biliverdin Reductase in the Choroid Plexus
por: Solár, Peter, et al.
Publicado: (2020)

Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update
por: Cimini, Flavia Agata, et al.
Publicado: (2022)

Metabolic Functions of Biliverdin IXβ Reductase in Redox-Regulated Hematopoietic Cell Fate
por: Bahou, Wadie F., et al.
Publicado: (2023)

Loss of Biliverdin Reductase Increases Oxidative Stress in the Cyanobacterium Synechococcus sp. PCC 7002
por: Schluchter, Wendy M., et al.
Publicado: (2023)

Soluble Adenylyl Cyclase Regulates Bile Salt‐Induced Apoptosis in Human Cholangiocytes
por: Chang, Jung‐Chin, et al.
Publicado: (2016)

Combined Effects of UGT1A1 and SLCO1B1 Variants on Chinese Adult Mild Unconjugated Hyperbilirubinemia
por: Bai, Jie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hfj7rq64j6h6gbt78676pbo443